A simple chat or text could stop diabetes before it starts

NCT ID NCT07553325

Not yet recruiting Prevention Sponsor: Johns Hopkins University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 14, 2026 · Updated 2 times

Summary

This pilot study tests whether a single, personalized conversation with a healthcare team member or a brief message through a patient portal can encourage adults with prediabetes to take action—like joining a diabetes prevention program or starting medication. Researchers will compare each approach to usual care in 120 patients at one clinic. The goal is to see if these simple strategies boost prevention steps.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Risk Informed Shared Decision-Making Strategy (RISE) and Low Touch Messaging Strategy (LTM)
What this could lead to: If successful, this could show that a brief, personalized risk discussion or a simple portal message can motivate people with prediabetes to join prevention programs or start medication.
What could go wrong: This is a small pilot study (120 people) at a single clinic, so results may not apply broadly. The interventions are very brief, and behavior change is hard to sustain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREDIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

glucose intolerance Insulin Resistance prediabetes syndrome type 2 diabetes mellitus prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PREDIABETES PREDIABETES (INSULIN RESISTANCE, IMPAIRED GLUCOSE TOLERANCE)

Contacts and locations

Locations

Johns Hopkins Community Physicians Frederick

Frederick, Maryland, 21702, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.